Join our community of traders FOR FREE!

  • Learn
  • Improve yourself
  • Get Rewards
Learn More

Futures on US West Texas Intermediate Crude Oil held ground above $83 per barrel on Friday despite a divergence between 2024 demand growth forecasts issued by the OPEC group and the International Energy Agency.

WTI Futures hit highs unseen since November 2022 on Thursday, while Brent Futures – their highest level since January, amid a sustained rally over the past 1 1/2 months.

The Organization of Petroleum Exporting Countries (OPEC) announced yesterday that it forecast an increase in global oil demand by 2.25 million barrels per day in 2024 and by 2.44 million barrels per day this year.

OPEC said that solid economic growth amid continued improvements in China would bolster oil consumption in 2024.

OPEC did not introduce any changes to its forecasts compared to July.

Meanwhile, the International Energy Agency (IEA) said on Friday that OPEC+ supply cuts could sharply reduce global inventories over the rest of 2023, potentially pushing oil prices even further up.

In case OPEC+ members maintain their current targets, oil inventories could decrease by 2.2 million barrels per day during the third quarter and by 1.2 million barrels per day during Q4.

“Deepening OPEC+ supply cuts have collided with improved macroeconomic sentiment and all-time high world oil demand,” the IEA said in its monthly report.

However, the energy watchdog also said it now forecast global oil demand growth to slow considerably to 1 million barrels per day in 2024, while citing a lackluster macroeconomic environment.

The new demand growth forecast has been revised down by 150,000 barrels per day compared to July and came in contrast with the OPEC forecast.

As of 12:54 GMT on Friday WTI Crude Oil Futures for September delivery were gaining 0.65% to trade at $83.36 per barrel.

At the same time, Brent Oil Futures for October delivery were gaining 0.66% on the day to trade at $86.97 per barrel.

TradingPedia.com is a financial media specialized in providing daily news and education covering Forex, equities and commodities. Our academies for traders cover Forex, Price Action and Social Trading.

Related News

  • Forex Market: AUD/USD trading outlook for January 18thForex Market: AUD/USD trading outlook for January 18th Friday’s trade saw AUD/USD within the range of 0.6824-0.7005. The pair closed at 0.6869, falling 1.66% on a daily basis, or at the sharpest rate since August 24th 2015, when it lost 2.23%. It has been the 8th drop in the past 10 trading days. […]
  • Gold trading outlook: futures rebound ahead of key US macro data stringGold trading outlook: futures rebound ahead of key US macro data string On Thursday gold for delivery in June traded within the range of $1,264.00-$1,281.20. Futures closed at $1,267.95, losing 0.52% compared to Wednesday’s close. It has been the 35th drop in the past 72 trading days. The daily high has been the […]
  • Market Observations for October 14th, Stocks to watch S&P 500 ceased its 3 day series of losses yesterday finishing with a .30% gain, Nasdaq outperformed with .73% and the Dow finished around flat. The market was cheered by the favorable JPM results, as the state of the major investment bank is […]
  • Forex Market: GBP/USD daily trading outlookForex Market: GBP/USD daily trading outlook Yesterday’s trade saw GBP/USD within the range of 1.4300-1.4440. The pair closed at 1.4322, edging down 0.08% on a daily basis, while extending the drop from April 20th. The daily high has been the highest level since March 30th, when a high […]
  • Forex Market: USD/CAD daily trading forecastForex Market: USD/CAD daily trading forecast Yesterday’s trade saw USD/CAD within the range of 1.1609-1.1624. The pair closed at 1.1617, losing 0.03% on a daily basis.At 10:57 GMT today USD/CAD was up 0.34% for the day to trade at 1.1658. The pair broke all three key daily […]
  • GlaxoSmithKline Plc share price up, appoints Mr. Philip Hampton as chairman to succeed GentGlaxoSmithKline Plc share price up, appoints Mr. Philip Hampton as chairman to succeed Gent GlaxoSmithKline Plc revealed in an official statement today that it will appoint Mr. Philip Hampton as next chairman to succeed Christopher Gent at a time when the company is trying to deal with downbeat sales in the U.S. and a bribery fine in […]